Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Net Change in Short-term Investments 2010-2025 | PRPH

ProPhase Labs net change in short-term investments from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
  
ProPhase Labs Annual Net Change in Short-term Investments
(Millions of US $)
2024 $3
2023 $4
2022 $-6
2021 $-22
2020 $-1
2019 $6
2018 $1
2017 $-19
2016 $N/A
2015 $N/A
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.014B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.099B 26.96
Zoetis (ZTS) United States $68.600B 24.89
Takeda Pharmaceutical (TAK) Japan $47.347B 9.66
Daiichi Sankyo, - (DSNKY) Japan $46.431B 23.80
BeOne Medicines - (ONC) Switzerland $33.857B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.333B 0.00
Summit Therapeutics (SMMT) United States $20.042B 0.00
Merck (MKKGY) Germany $16.317B 10.61
Shionogi (SGIOY) Japan $14.615B 14.64
United Therapeutics (UTHR) United States $13.948B 12.07
Neurocrine Biosciences (NBIX) United States $13.572B 40.49
Orion OYJ (ORINY) Finland $11.336B 27.32
IPSEN (IPSEY) France $11.117B 0.00
Madrigal Pharmaceuticals (MDGL) United States $9.433B 0.00
Eisai (ESAIY) $9.158B 10.33
Corcept Therapeutics (CORT) United States $7.331B 61.57
Grifols, S.A (GRFS) Spain $6.766B 0.00
Ionis Pharmaceuticals (IONS) United States $6.722B 0.00
Stevanato Group S.p.A (STVN) Italy $6.557B 38.66
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.699B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.946B 14.00
Crinetics Pharmaceuticals (CRNX) United States $2.913B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.837B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 20.71
Catalyst Pharmaceuticals (CPRX) United States $2.440B 8.17
Centessa Pharmaceuticals (CNTA) United Kingdom $2.248B 0.00
Ocular Therapeutix (OCUL) United States $2.144B 0.00
Dyne Therapeutics (DYN) United States $1.903B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.801B 0.00
Guardian Pharmacy Services (GRDN) United States $1.648B 0.00
Harrow (HROW) United States $1.427B 0.00
ARS Pharmaceuticals (SPRY) United States $1.373B 0.00
Xeris Biopharma Holdings (XERS) United States $1.284B 0.00
Evotec AG (EVO) Germany $1.239B 0.00
Collegium Pharmaceutical (COLL) United States $1.215B 6.64
Enliven Therapeutics (ELVN) United States $1.204B 0.00
Cronos Group (CRON) Canada $0.977B 0.00
Akebia Therapeutics (AKBA) United States $0.819B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.817B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.747B 7.69
ProKidney (PROK) United States $0.700B 0.00
Theravance Biopharma (TBPH) United States $0.695B 57.50
KalVista Pharmaceuticals (KALV) United States $0.662B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Relay Therapeutics (RLAY) United States $0.610B 0.00
Siga Technologies (SIGA) United States $0.608B 7.51
Tourmaline Bio (TRML) United States $0.604B 0.00
Bioventus (BVS) United States $0.601B 14.54
Elite Pharmaceuticals (ELTP) United States $0.586B 0.00
USANA Health Sciences (USNA) United States $0.579B 11.87
Savara (SVRA) United States $0.572B 0.00
Xencor (XNCR) United States $0.563B 0.00
Oruka Therapeutics (ORKA) United States $0.555B 0.00
Nektar Therapeutics (NKTR) United States $0.547B 0.00
Zevra Therapeutics (ZVRA) United States $0.528B 0.00
Esperion Therapeutics (ESPR) United States $0.442B 0.00
Nanobiotix S.A (NBTX) France $0.402B 0.00
Aldeyra Therapeutics (ALDX) United States $0.353B 0.00
Larimar Therapeutics (LRMR) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.305B 0.00
Altimmune (ALT) United States $0.304B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.291B 18.97
AleAnna (ANNA) United States $0.283B 0.00
Galectin Therapeutics (GALT) United States $0.266B 0.00
Lexeo Therapeutics (LXEO) United States $0.264B 0.00
Heron Therapeutics (HRTX) United States $0.216B 0.00
Lyell Immunopharma (LYEL) United States $0.211B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.206B 31.75
OmniAb (OABI) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.196B 0.00
Korro Bio (KRRO) United States $0.190B 0.00
MediWound (MDWD) Israel $0.182B 0.00
Journey Medical (DERM) United States $0.181B 0.00
China SXT Pharmaceuticals (SXTC) China $0.174B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
MEI Pharma (MEIP) United States $0.171B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Wellgistics Health (WGRX) United States $0.145B 0.00
Inhibikase Therapeutics (IKT) United States $0.137B 0.00
Profound Medical (PROF) Canada $0.135B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.123B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cassava Sciences (SAVA) United States $0.109B 0.00
Dominari Holdings (DOMH) United States $0.098B 0.00
Cardiol Therapeutics (CRDL) Canada $0.096B 0.00
Surrozen (SRZN) United States $0.095B 0.00
Champions Oncology (CSBR) United States $0.093B 21.03
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.085B 0.00
Liminatus Pharma (LIMN) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
Context Therapeutics (CNTX) United States $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.069B 0.00
Karyopharm Therapeutics (KPTI) United States $0.065B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.91
Fractyl Health (GUTS) United States $0.051B 0.00
Plus Therapeutics (PSTV) United States $0.050B 0.00
Tempest Therapeutics (TPST) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Klotho Neurosciences (KLTO) United States $0.045B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
FibroGen (FGEN) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Incannex Healthcare (IXHL) Australia $0.021B 0.00
Mangoceuticals (MGRX) United States $0.020B 0.00
Ainos (AIMD) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ESSA Pharma (EPIX) Canada $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Vyome Holdings (HIND) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Aditxt (ADTX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.74
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.59
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00